Bone mineral density in statin users: a population-based analysis from a Spanish cohort (Q50489504)

14 March 2018

title

Bone mineral density in statin users: a population-based analysis from a Spanish cohort (English)

1 reference

14 March 2018

author name string

José L Hernández

1

1 reference

14 March 2018

José M Olmos

2

1 reference

14 March 2018

Galo Romaña

3

1 reference

14 March 2018

Josefina Martinez

4

1 reference

14 March 2018

Jesús Castillo

5

1 reference

14 March 2018

Irina Yezerska

6

1 reference

14 March 2018

Gabriel Pinedo

7

1 reference

14 March 2018

Jesús González-Macías

8

1 reference

14 March 2018

publication date

20 June 2013

1 reference

14 March 2018

Journal of Bone and Mineral Metabolism

published in

1 reference

14 March 2018

volume

32

1 reference

14 March 2018

issue

2

1 reference

14 March 2018

page(s)

184-191

1 reference

14 March 2018

Pleiotropic effects of statins

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Prospective, double blind, randomized, controlled trial of simvastatin in human fracture healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Stimulation of bone formation in vitro and in rodents by statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

HMG CoA reductase inhibitors and the skeleton: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Effects of statins on bone mineral density: a meta-analysis of clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

The role of statins as potential targets for bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Metabolic syndrome and bone metabolism: the Camargo Cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Serum lipids and bone metabolism in Spanish men: the Camargo cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

A systematic review and meta-analysis on the therapeutic equivalence of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Variation in Plasma Calcium with Induced Changes in Plasma Specific Gravity, Total Protein, and Albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Bone turnover markers in Spanish adult men The Camargo Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Lipid levels and bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Short-term reduction in bone markers with high-dose simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

The effect of fluvastatin on parameters of bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Effects of Atorvastatin on Bone in Postmenopausal Women with Dyslipidemia: A Double-Blind, Placebo-Controlled, Dose-Ranging Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-013-0481-6

Effect of atorvastatin on bone mineral density in patients with acute coronary syndrome.

21 January 2018

1 reference

12 December 2020

Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes As

1 reference

12 December 2020

Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts.

1 reference

12 December 2020

Biomechanical indices of the femoral neck estimated from the standard DXA output: age- and sex-related differences

1 reference

12 December 2020

10.1007/S00774-013-0481-6

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018